Zelira Partners with SprinJene® to Launch CBD Toothpaste in United States.

Zelira's first Over-the-Counter (OTC) formulation provides access to the rapidly expanding
market for hemp-derived CBD products.

Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF), in partnership with SprinJene®, a leader in natural oral care products, is pleased to announce the launch of its proprietary CBD toothpaste in the United States of America (USA).


The CBD toothpaste is a proprietary formulation developed by Zelira and SprinJene's® CEO and Founder Dr Sayed Ibrahim. The product is the first of several scientifically formulated, hemp-derived, oral care products containing cannabinoids, including broad-spectrum CBD, that will be created and launched under the Zelira Oral Care subsidiary that has partnered with the SprinJene® brand as announced in September (www.zeliraoralcare.com).


Research shows that incorporating CBD into oral/dental care results in health benefits
including naturally eliminating decay-causing bacteria, reducing gum inflammation,
restoring pH balance and increasing remineralisation, reducing bone loss associated
with gum disease, and helping to improve overall health. The Zelira-SprinJene® CBD
Toothpaste uses broad-spectrum, THC-free CBD distillate derived from hemp. This
provides Zelira-SprinJene® users with the full benefits of a wide array of cannabinoids,
with no psychoactive effects.
The Zelira-SprinJene® CBD product will be distributed in the USA through SprinJene's®
existing distribution channels including retail stores such as Bed Bath & Beyond,
Central Market, Sprouts, Lassen's, Haggens, and VitaCos and e-commerce platforms
such as Amazon. Discussions are ongoing to access SprinJene's® global distribution
networks in France, Russia, UK, Singapore, Ukraine, China, Morocco, United Arab
Emirates, Saudi Arabia and Sudan Shoprite.

The SprinJene® brand is built on harnessing the power of natural ingredients to protect and improve our oral health, and CBD with its inherent anti-inflammatory, antibacterial and homeostatic properties are shown to be powerful tools in that fightSprinJene Ceo, Dr. Syed Ibrahim

"Research is showing
that cannabinoids will be a major part of the future of oral1-3 and Zelira was the perfect partner for
SprinJene® to set the industry standard in broad spectrum, hemp-derived oral care formulations."


"SprinJene® was an early adopter of nature-based oral care, and they are continuing to innovate now by recognising the effectiveness of CBD and other cannabinoids in improving our head-to-toe health," says Dr Oludare Odumosu, Zelira's CEO & Managing Director (USA) "Zelira is thrilled to enter the national oral care market alongside a company that values the harmony of nature and science as much as we do."

To learn more about Zeliria visit the company HQ here.

Disclaimer: Past performance is not an indicator of future performance.

Get the Latest Marijuana News &
Content in your Inbox!

All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors

Amaan Anand
Amaan Anand

Amaan is currently studying a Law/Media degree at UNSW, with a passion for the cannabis industry and the plant itself. Amaan seeks to spread valuable information about cannabis and thebroader industry for the greater good of the general public and enthusiasts alike.